Form 4: Nevro Corp CEO Kevin Thornal Reports Acquisition of Restricted Stock Units
SEC Form 4 Filing
Nevro Corp's CEO, Kevin Thornal, reports the acquisition of restricted stock units and disposition of common stock.
Summary
- On March 7, 2024, Kevin Thornal, the President and CEO of Nevro Corp, acquired 150,581 restricted stock units (RSUs) at a price of $0.
- These RSUs will vest over time, with one-third vesting on March 7, 2025, and the remainder vesting quarterly thereafter until fully vested by the third anniversary of the grant date, contingent upon continued service.
- Thornal also disposed of 286,204 shares of common stock.
Sentiment
Score: 6
Explanation: The document is a routine regulatory filing. The RSU grant is a positive sign of aligning management with shareholder interests, but the disposition of shares is a neutral event.
Positives
- The grant of RSUs to the CEO aligns his interests with the long-term performance of the company.
Future Outlook
The vesting schedule of the RSUs extends over three years, indicating a long-term commitment from the CEO.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The RSU grant aligns the CEO's interests with shareholders, potentially driving long-term value.
Key Dates
| Date | Description |
|---|---|
| 03/07/2024 | Date of transaction: Acquisition of RSUs and disposition of common stock. |
| 03/07/2025 | First vesting date for 1/3 of the RSUs. |
| 03/11/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.